CD8A and infection: Remarkably, blockage or ablation of PD-1 (through the administration of anti-PD-L1 antibodies and the use of PD-1−/− mice, respectively) prevented the impairment of the activation of CD8+ T cells, leading to enhanced protective responses in subsequent infections with hMPV [134].